ArticleInfection and immunity2005
CD40 signaling in macrophages induces activity against an intracellular pathogen independently of gamma interferon and reactive nitrogen intermediates.
Article in Infection and immunity, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 59 citations in OpenAlex.
- Enhancing natural killer cell anti-tumour activity through macrophage manipulation.Frontiers in immunology · 2025Review
- Autophagy in protists and their hosts: When, how and why?Autophagy reports · 2023Article
- Recent Advances in the Roles of Autophagy and Autophagy Proteins in Host Cells DuringFrontiers in cell and developmental biology · 2021Review
- Escape from X chromosome inactivation and female bias of autoimmune diseases.Molecular medicine (Cambridge, Mass.) · 2020Review
- The zebrafish as a novel model for theDisease models & mechanisms · 2020Article
- A Comparison of Transcriptional Diversity of Swine Macrophages Infected With TgHB1 Strain ofFrontiers in cellular and infection microbiology · 2020Article
- The Interplay of Host Autophagy and Eukaryotic Pathogens.Frontiers in cell and developmental biology · 2018Review
- Type II Toxoplasma gondii induction of CD40 on infected macrophages enhances interleukin-12 responses.Infection and immunity · 2014Article
- Tumor necrosis factor-alpha-converting enzyme activities and tumor-associated macrophages in breast cancer.Immunologic research · 2014Review
- The early phase transcriptome of bovine monocyte-derived macrophages infected with Staphylococcus aureus in vitro.BMC genomics · 2013Article
- Toxoplasma gondii-induced activation of EGFR prevents autophagy protein-mediated killing of the parasite.PLoS pathogens · 2013Article
- The protein kinase double-stranded RNA-dependent (PKR) enhances protection against disease cause by a non-viral pathogen.PLoS pathogens · 2013Article
- Immune response and immunopathology during toxoplasmosis.Seminars in immunopathology · 2012Review
- CD40 and tumour necrosis factor-α co-operate to up-regulate inducuble nitric oxide synthase expression in macrophages.Immunology · 2012Article
- Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPsPharmaceuticals (Basel, Switzerland) · 2011Review
- A critical role for SOCS3 in innate resistance to Toxoplasma gondii.Cell host & microbe · 2011Article
- Article
- HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3.PloS one · 2010Article
- CD40 and the immune response to parasitic infections.Seminars in immunology · 2009Review
- Autophagosome-independent essential function for the autophagy protein Atg5 in cellular immunity to intracellular pathogens.Cell host & microbe · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Gamma interferon (IFN-gamma) is the major inducer of classical activation of macrophages. Classically activated mouse macrophages acquire antimicrobial activity that is largely dependent on the production of reactive nitrogen intermediates. However, protection against important intracellular pathogens can take place in the absence of IFN-gamma and nitric oxide synthase 2 (NOS2). Using Toxoplasma gondii as a model, we investigated if CD40 signaling generates mouse macrophages with effector function against an intracellular pathogen despite the absence of priming with IFN-gamma and lack of production of reactive nitrogen intermediates. CD40-stimulated macrophages acquired anti-T. gondii activity that was not inhibited by a neutralizing anti-IFN-gamma monoclonal antibody but was ablated by the neutralization of tumor necrosis factor alpha (TNF-alpha). Moreover, while the induction of anti-T. gondii activity in response to CD40 stimulation was unimpaired in macrophages from IFN-gamma(-/-) mice, macrophages from TNF receptor 1/2(-/-) mice failed to respond to CD40 engagement. In contrast to IFN-gamma-lipopolysaccharide, CD40 stimulation did not induce NOS2 expression and did not trigger production of reactive nitrogen intermediates. Neither N(G)-monomethyl-l-arginine nor diphenyleneiodonium chloride affected the induction of anti-T. gondii activity in response to CD40. Finally, macrophages from NOS2(-/-) mice acquired anti-T. gondii activity in response to CD40 stimulation that was similar to that of macrophages from wild-type mice. These results demonstrate that CD40 induces the antimicrobial activity of macrophages against an intracellular pathogen despite the lack of two central features of classically activated macrophages: priming with IFN-gamma and production of reactive nitrogen intermediates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.